ACP-105
A-C-P ten-five
Category
Compound type
Phase / Status
Research chemical, not approved for human use
Standard Dose
As directed
Half-life
Plasma elimination
Route(s)
Oral
Research Stage
Research phase not specified; exercise appropriate caution.
Overview
ACP-105 is a SARM-like compound discussed for supporting lean tissue and bone-related outcomes. The appeal is that, in preclinical discussions, it may aim for stronger "tissue selective" effects - while overall long-term human safety and efficacy remain uncertain. If you're reading about it, treat all dosing and performance claims as preliminary and stick to verified scientific sources.
Plain-language summary
ACP-105 is a SARM-like compound discussed for supporting lean tissue and bone-related outcomes. The appeal is that, in preclinical discussions, it may aim for stronger "tissue selective" effects - while overall long-term human safety and efficacy remain uncertain. If you're reading about it, treat all dosing and performance claims as preliminary and stick to verified scientific sources.
Administration Routes
- Oral
Also known as
Mechanisms
Selective androgen receptor modulator
Detailed mechanism
Selective modulator of androgen receptors with tissue-specific effects, promoting anabolic activity in muscle and bone while minimizing effects on prostate and sebaceous glands.
Safety
Side effects
- Testosterone suppression
- Potential liver stress
- Lipid changes
- Unknown long-term effects
Reported benefits
- Increased muscle mass
- Improved bone density
- Enhanced strength
- Reduced prostate effects
Safety profile
Limited human safety data. Use only in research settings.
Clinical trials
Preclinical and early clinical research phase. Not approved for human consumption.
Structure
Verified structure
ACP-105
Exact 2D structure can be rendered from a PubChem-backed canonical SMILES string.
- Chemical Formula
- C16H19ClN2O
- Molecular Weight
- 290.79 g/mol
- CAS Number
- 899821-23-9
- InChIKey
- OUEODVPKPRQETQ-UHFFFAOYSA-N
Stack Context
Stacks with
References
- 1View source
Selective androgen receptor modulators in preclinical and clinical development
2008
- 2View source
Nonsteroidal selective androgen receptor modulators (SARMs): dissociating the anabolic and androgenic activities of the androgen receptor for therapeutic benefit
2009
- 3View source
The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial
2011
This profile summarizes research literature for education only. It is not medical advice, and it does not diagnose, treat, or recommend a dose. Consult a qualified professional before changing a protocol.